CDKN2A and pancreatic neoplasm: Pancreatic cancer development is driven by somatic mutations in well-known cancer genes, including frequent activating mutations of the KRAS oncogene, and inactivating mutations of the CDKN2A (p16INK4A), SMAD4, and TP53 tumor suppressor genes [5].